SAR 12.7
(0.79%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 139.65 Million | 123.09 Million | -23.04 Million | -3.05 Million | -10.65 Million | 37.89 Million |
Net Income | 72.2 Million | -20.73 Million | -104 Million | 4 Million | 7.64 Million | 3.2 Million |
Depreciation & Amortization | 5.36 Million | 5.52 Million | 4.83 Million | 4.8 Million | 3.14 Million | 2.57 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 105.49 Million | 138.41 Million | 78.45 Million | -7.59 Million | -18.57 Million | 22.19 Million |
Other non-cash items | -43.41 Million | -119 Thousand | -2.32 Million | -4.27 Million | -2.86 Million | 9.91 Million |
Investing Cash Flow | -480.54 Million | 164.95 Million | -66.78 Million | 75.99 Million | -5.36 Million | -21.99 Million |
Investments in PPE | -2.95 Million | -2.5 Million | -3.75 Million | -4.26 Million | -1.73 Million | -5.17 Million |
Acquisitions | 563.35 Million | -182.36 Million | - | - | -1.35 Million | 1.4 Million |
Investment purchases | -563.35 Million | -1.25 Million | -63.03 Million | - | -10.21 Million | -19.73 Million |
Sales/Maturities of investments | 47.5 Million | 182.36 Million | - | 5 Million | 23.93 Million | 5.15 Million |
Other Investing Activities | -525.09 Million | 168.71 Million | -63.03 Million | 75.25 Million | -15.98 Million | -3.64 Million |
Financing Cash Flow | -1.8 Million | 143.39 Million | -2.13 Million | -2.43 Million | 7.12 Million | - |
Debt repayment | -1.8 Million | -3.72 Million | -2.13 Million | -2.43 Million | -7.12 Million | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 147.12 Million | - | - | - | - |
Other Financing Activities | -1.8 Million | 147.12 Million | -2.13 Million | -2.43 Million | 14.24 Million | - |
Accounts receivables | - | -17.85 Million | -1.56 Million | -6.14 Million | 6.06 Million | -14.55 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 105.49 Million | 156.27 Million | 80.01 Million | -1.44 Million | -24.63 Million | 24.05 Million |
Cash at beginning of period | 484.33 Million | 52.97 Million | 144.93 Million | 77.47 Million | 93.49 Million | 77.59 Million |
Cash at end of period | 141.63 Million | 484.41 Million | 52.97 Million | 147.97 Million | 77.47 Million | 93.49 Million |
Capital Expenditure | -2.95 Million | -2.5 Million | -3.75 Million | -4.26 Million | -1.73 Million | -5.17 Million |
Effect of forex changes on cash | - | - | - | - | -7.12 Million | - |
Net cash flow / Change in cash | -342.69 Million | 431.44 Million | -91.96 Million | 70.49 Million | -16.01 Million | 15.89 Million |
Free Cash Flow | 136.7 Million | 120.58 Million | -26.79 Million | -7.32 Million | -12.38 Million | 32.71 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.89 Million | 24.99 Million | 72.2 Million | 20.04 Million | 32.86 Million | 14.95 Million |
Depreciation & Amortization | 990 Thousand | 1.77 Million | 5.36 Million | 1.11 Million | 1.2 Million | 1.5 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 53.87 Million | -77.47 Million | 105.49 Million | -14.23 Million | 45.93 Million | 6.58 Million |
Other non-cash items | 18.18 Million | -5.79 Million | -43.41 Million | -9.58 Million | -27.34 Million | -6.43 Million |
Investing Cash Flow | -65.92 Million | 8.39 Million | -480.54 Million | -532.41 Million | 26.29 Million | -504 Thousand |
Investments in PPE | -636 Thousand | -1.56 Million | -2.95 Million | -624 Thousand | -405 Thousand | -504 Thousand |
Acquisitions | - | - | 563.35 Million | 563.35 Million | - | - |
Investment purchases | -54.7 Million | -788 Thousand | -563.35 Million | -563.35 Million | - | - |
Sales/Maturities of investments | 154 Thousand | - | 47.5 Million | 20 Million | - | - |
Other Investing Activities | -10.74 Million | 10.74 Million | -525.09 Million | -551.79 Million | 26.69 Million | -488 Thousand |
Financing Cash Flow | 1.68 Million | -3.48 Million | -1.8 Million | -472 Thousand | - | -322 Thousand |
Debt repayment | - | -3.48 Million | -1.8 Million | -472 Thousand | - | -322 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 1.68 Million | - | - | -472 Thousand | - | -322 Thousand |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 76.72 Million | -76.72 Million | 105.49 Million | -14.23 Million | 45.93 Million | 6.58 Million |
Cash at beginning of period | 130.14 Million | 185.28 Million | 484.33 Million | 677.18 Million | 598.23 Million | 582.45 Million |
Cash at end of period | 139.84 Million | 130.14 Million | 141.63 Million | 141.63 Million | 677.18 Million | 598.23 Million |
Capital Expenditure | -636 Thousand | -1.56 Million | -2.95 Million | -624 Thousand | -405 Thousand | -504 Thousand |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | 9.7 Million | -55.14 Million | -342.69 Million | -535.54 Million | 78.95 Million | 15.78 Million |
Free Cash Flow | 73.31 Million | -61.61 Million | 136.7 Million | -3.28 Million | 52.25 Million | 16.1 Million |
KREBSBIO
VRSRF
GREAVESCOT
218A
600282
603663